Autologous blood stem cell transplantation (ABSCT) in high-risk myeloma (MM).
Bone Marrow Transplant Unit, Hôpital Haut-Levêque, CHR Bordeaux, France.
G
G
Marit
J M
JM
Boiron
J L
JL
Pico
C
C
Foures
A
A
Rice
P
P
Cony-Makhoul
P
P
Bernard
A
A
Broustet
J
J
Reiffers
D000328:Adult; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007937:Leukapheresis; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000628:therapy*; D012074:Remission Induction; D012307:Risk Factors; D014182:Transplantation, Autologous
D003520:Cyclophosphamide; D008558:Melphalan